Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$39.5 million.

  • Accendra Health's Cash from Investing Activities fell 4514.69% to -$39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.9 million, marking a year-over-year decrease of 8700.74%. This contributed to the annual value of -$116.5 million for FY2024, which is 1509.68% up from last year.
  • As of Q3 2025, Accendra Health's Cash from Investing Activities stood at -$39.5 million, which was down 4514.69% from -$52.9 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Cash from Investing Activities ranged from a high of -$1.9 million in Q1 2024 and a low of -$1.6 billion during Q1 2022
  • Moreover, its 5-year median value for Cash from Investing Activities was -$32.8 million (2022), whereas its average is -$118.6 million.
  • Per our database at Business Quant, Accendra Health's Cash from Investing Activities tumbled by 2387999.7% in 2022 and then soared by 9784.63% in 2023.
  • Accendra Health's Cash from Investing Activities (Quarter) stood at -$21.0 million in 2021, then crashed by 55.71% to -$32.8 million in 2022, then dropped by 18.75% to -$38.9 million in 2023, then plummeted by 34.41% to -$52.3 million in 2024, then grew by 24.55% to -$39.5 million in 2025.
  • Its Cash from Investing Activities was -$39.5 million in Q3 2025, compared to -$52.9 million in Q2 2025 and -$48.2 million in Q1 2025.